These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21396578)

  • 1. Septo-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond.
    McCabe MJ; Alatzoglou KS; Dattani MT
    Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):115-24. PubMed ID: 21396578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of septo-optic dysplasia.
    Kelberman D; Dattani MT
    Pituitary; 2007; 10(4):393-407. PubMed ID: 17587179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Septo-optic dysplasia - novel insights into the aetiology.
    Kelberman D; Dattani MT
    Horm Res; 2008; 69(5):257-65. PubMed ID: 18259104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Septo-optic dysplasia complex: a heterogeneous malformation syndrome.
    Polizzi A; Pavone P; Iannetti P; Manfré L; Ruggieri M
    Pediatr Neurol; 2006 Jan; 34(1):66-71. PubMed ID: 16376284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia.
    Rainbow LA; Rees SA; Shaikh MG; Shaw NJ; Cole T; Barrett TG; Kirk JM
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):163-8. PubMed ID: 15670191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of SoxB1-dependent Sonic hedgehog expression in the hypothalamus causes septo-optic dysplasia.
    Zhao L; Zevallos SE; Rizzoti K; Jeong Y; Lovell-Badge R; Epstein DJ
    Dev Cell; 2012 Mar; 22(3):585-96. PubMed ID: 22421044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism.
    McNay DE; Turton JP; Kelberman D; Woods KS; Brauner R; Papadimitriou A; Keller E; Keller A; Haufs N; Krude H; Shalet SM; Dattani MT
    J Clin Endocrinol Metab; 2007 Feb; 92(2):691-7. PubMed ID: 17148560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Natural course of septo-optic dysplasia: retrospective analysis of 20 cases].
    León-Gonzalez M; García-Peñas JJ; Puertas-Bordallo D; López-Pino MA; Argente-Oliver J; Cantarín-Extremera V
    Rev Neurol; 2012 Mar; 54(6):321-31. PubMed ID: 22403144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.
    Thomas PQ; Dattani MT; Brickman JM; McNay D; Warne G; Zacharin M; Cameron F; Hurst J; Woods K; Dunger D; Stanhope R; Forrest S; Robinson IC; Beddington RS
    Hum Mol Genet; 2001 Jan; 10(1):39-45. PubMed ID: 11136712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse.
    Dattani MT; Martinez-Barbera JP; Thomas PQ; Brickman JM; Gupta R; Mårtensson IL; Toresson H; Fox M; Wales JK; Hindmarsh PC; Krauss S; Beddington RS; Robinson IC
    Nat Genet; 1998 Jun; 19(2):125-33. PubMed ID: 9620767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of mouse models carrying the I26T and R160C substitutions in the transcriptional repressor HESX1 as models for septo-optic dysplasia and hypopituitarism.
    Sajedi E; Gaston-Massuet C; Signore M; Andoniadou CL; Kelberman D; Castro S; Etchevers HC; Gerrelli D; Dattani MT; Martinez-Barbera JP
    Dis Model Mech; 2008; 1(4-5):241-54. PubMed ID: 19093031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic forms of hypopituitarism and their manifestation in the neonatal period.
    Alatzoglou KS; Dattani MT
    Early Hum Dev; 2009 Nov; 85(11):705-12. PubMed ID: 19762173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of septo-optic dysplasia.
    Dattani ML; Martinez-Barbera J; Thomas PQ; Brickman JM; Gupta R; Wales JK; Hindmarsh PC; Beddington RS; Robinson IC
    Horm Res; 2000; 53 Suppl 1():26-33. PubMed ID: 10895039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of transcription factors in midline central nervous system and pituitary defects.
    Kelberman D; Dattani MT
    Endocr Dev; 2009; 14():67-82. PubMed ID: 19293576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel homozygous HESX1 mutation causes panhypopituitarism without midline defects and optic nerve anomalies.
    Durmaz B; Cogulu O; Dizdarer C; Stobbe H; Pfaeffle R; Ozkinay F
    J Pediatr Endocrinol Metab; 2011; 24(9-10):779-82. PubMed ID: 22145475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into septo-optic dysplasia.
    Saranac L; Gucev Z
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):123-7. PubMed ID: 24802313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous mutation of HESX1 causing hypopituitarism and multiple anatomical malformations without features of septo-optic dysplasia.
    Corneli G; Vivenza D; Prodam F; Di Dio G; Vottero A; Rapa A; Bellone S; Bernasconi S; Bona G
    J Endocrinol Invest; 2008 Aug; 31(8):689-93. PubMed ID: 18852528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental disorders of the hypothalamus and pituitary gland associated with congenital hypopituitarism.
    Mehta A; Dattani MT
    Best Pract Res Clin Endocrinol Metab; 2008 Feb; 22(1):191-206. PubMed ID: 18279788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HESX1 and Septo-Optic Dysplasia.
    Dattani MT; Robinson IC
    Rev Endocr Metab Disord; 2002 Dec; 3(4):289-300. PubMed ID: 12424431
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders.
    Brickman JM; Clements M; Tyrell R; McNay D; Woods K; Warner J; Stewart A; Beddington RS; Dattani M
    Development; 2001 Dec; 128(24):5189-99. PubMed ID: 11748154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.